Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay

A. Petrackova, A. Smrzova, P. Gajdos, M. Schubertova, P. Schneiderova, P. Kromer, V. Snasel, M. Skacelova, F. Mrazek, J. Zadrazil, P. Horak, E. Kriegova,

. 2017 ; 14 (-) : 32. [pub] 20171003

Language English Country England, Great Britain

Document type Journal Article

Grant support
NV15-28659A MZ0 CEP Register

BACKGROUND: Systemic lupus erythematosus (SLE) is a remarkably heterogeneous autoimmune disease. Despite tremendous efforts, our knowledge of serum protein patterns in severe SLE phenotypes is still limited. We investigated the serum protein pattern of SLE, with special emphasis on irreversible organ damage and active lupus nephritis (LN) as assessed by renal Systemic Lupus Erythematosus Disease Activity Index. METHODS: We used proximity extension immunoassay (PEA, Proseek Multiplex, Olink) to assess the serum levels of ninety-two inflammation-related proteins in Czech patients with SLE (n = 75) and age-matched healthy control subjects (n = 23). Subgroup analysis was carried out on the basis of organ damage (with/without, 42/33) and biopsy-proven LN (with/without, 27/48; active LN, n = 13; inactive LN, n = 14). RESULTS: Of thirty deregulated proteins between SLE and the healthy controls (Pcorr  < 0.05), the top upregulated proteins in SLE were sirtuin 2, interleukin 18 (IL18), and caspase 8 (Pcorr  < 0.0006). Of these, sirtuin 2 and caspase 8 had not yet been reported with SLE. Elevated levels of IL8, CCL2/MCP1, CCL11, and MMP10 (Pcorr  < 0.05) were detected in patients with organ damage for which the serum levels of CCL11 and MMP10 were particularly informative in organ damage prediction. Comparing patients based on LN, elevated levels of CSF1, sIL15RA, sCD40, sCX3CL1, caspase 8, sIL18R1, bNGF, and GDNF (Pcorr  < 0.05) were detected in active LN. Except GDNF, all LN-associated markers showed usefulness in prediction of active renal disease. CONCLUSIONS: This highly sensitive PEA analysis identified the serum pattern of SLE, organ damage, and active LN, with many novel candidate proteins detected. Their exact role and suitability as biomarkers in SLE deserve further investigation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18001015
003      
CZ-PrNML
005      
20201022153137.0
007      
ta
008      
180116s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12014-017-9167-8 $2 doi
035    __
$a (PubMed)29026368
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Petrackova, Anna $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, 775 15 Olomouc, Czech Republic.
245    10
$a Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay / $c A. Petrackova, A. Smrzova, P. Gajdos, M. Schubertova, P. Schneiderova, P. Kromer, V. Snasel, M. Skacelova, F. Mrazek, J. Zadrazil, P. Horak, E. Kriegova,
520    9_
$a BACKGROUND: Systemic lupus erythematosus (SLE) is a remarkably heterogeneous autoimmune disease. Despite tremendous efforts, our knowledge of serum protein patterns in severe SLE phenotypes is still limited. We investigated the serum protein pattern of SLE, with special emphasis on irreversible organ damage and active lupus nephritis (LN) as assessed by renal Systemic Lupus Erythematosus Disease Activity Index. METHODS: We used proximity extension immunoassay (PEA, Proseek Multiplex, Olink) to assess the serum levels of ninety-two inflammation-related proteins in Czech patients with SLE (n = 75) and age-matched healthy control subjects (n = 23). Subgroup analysis was carried out on the basis of organ damage (with/without, 42/33) and biopsy-proven LN (with/without, 27/48; active LN, n = 13; inactive LN, n = 14). RESULTS: Of thirty deregulated proteins between SLE and the healthy controls (Pcorr  < 0.05), the top upregulated proteins in SLE were sirtuin 2, interleukin 18 (IL18), and caspase 8 (Pcorr  < 0.0006). Of these, sirtuin 2 and caspase 8 had not yet been reported with SLE. Elevated levels of IL8, CCL2/MCP1, CCL11, and MMP10 (Pcorr  < 0.05) were detected in patients with organ damage for which the serum levels of CCL11 and MMP10 were particularly informative in organ damage prediction. Comparing patients based on LN, elevated levels of CSF1, sIL15RA, sCD40, sCX3CL1, caspase 8, sIL18R1, bNGF, and GDNF (Pcorr  < 0.05) were detected in active LN. Except GDNF, all LN-associated markers showed usefulness in prediction of active renal disease. CONCLUSIONS: This highly sensitive PEA analysis identified the serum pattern of SLE, organ damage, and active LN, with many novel candidate proteins detected. Their exact role and suitability as biomarkers in SLE deserve further investigation.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Smrzova, Andrea $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, University Hospital, Palacky University, Olomouc, Czech Republic.
700    1_
$a Gajdos, Petr $u Department of Computer Science, Faculty of Electrical Engineering and Computer Science, Technical University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Schubertova, Marketa $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, University Hospital, Palacky University, Olomouc, Czech Republic.
700    1_
$a Schneiderova, Petra $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, 775 15 Olomouc, Czech Republic.
700    1_
$a Kromer, Pavel $u Department of Computer Science, Faculty of Electrical Engineering and Computer Science, Technical University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Snasel, Vaclav $u Department of Computer Science, Faculty of Electrical Engineering and Computer Science, Technical University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Skacelova, Martina $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, University Hospital, Palacky University, Olomouc, Czech Republic.
700    1_
$a Mrazek, Frantisek $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, 775 15 Olomouc, Czech Republic.
700    1_
$a Zadrazil, Josef $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, University Hospital, Palacky University, Olomouc, Czech Republic.
700    1_
$a Horak, Pavel $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, University Hospital, Palacky University, Olomouc, Czech Republic.
700    1_
$a Kriegova, Eva $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, 775 15 Olomouc, Czech Republic.
773    0_
$w MED00173375 $t Clinical proteomics $x 1542-6416 $g Roč. 14, č. - (2017), s. 32
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29026368 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180116 $b ABA008
991    __
$a 20201022153134 $b ABA008
999    __
$a ind $b bmc $g 1268410 $s 997677
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 14 $c - $d 32 $e 20171003 $i 1542-6416 $m Clinical proteomics $n Clin Proteomics $x MED00173375
GRA    __
$a NV15-28659A $p MZ0
LZP    __
$a Pubmed-20180116

Find record

Citation metrics

Logged in users only

Archiving options

Loading data ...